An engineered aldolase enables the biocatalytic synthesis of 2′-functionalized nucleoside analogues
Nucleosides functionalized at the 2'-position play a crucial role in therapeutics, serving as both small-molecule drugs and modifications in therapeutic oligonucleotides. However, the synthesis of these molecules often presents substantial synthetic challenges. Here we present an approach to the synthesis of 2'-functionalized nucleosides based on enzymes from the purine nucleoside salvage pathway. Initially, active-site variants of deoxyribose-5-phosphate aldolase were generated for the highly stereoselective synthesis of d-ribose-5-phosphate analogues with a broad range of functional groups at the 2-position. Thereafter, these 2-modified pentose phosphates were converted into 2'-modified purine analogues by construction of one-pot multienzyme cascade reactions, leading to the synthesis of guanosine (2'-OH) and adenosine (2'-OH, 2'-Me, 2'-F) analogues. This cascade allows for the control of the 2'-functional group alongside 2-stereochemistry. Our findings demonstrate the capability of these biocatalytic cascades to efficiently generate 2'-functionalized nucleosides, starting from simple starting materials.
Authors
- Rachel S. Heath (ORCID: https://orcid.org/0000-0003-1910-8268)
- Christian Schnepel (ORCID: https://orcid.org/0000-0002-4331-2675)
- Peter D. Smith (ORCID: https://orcid.org/0000-0001-5312-9893)
- Matthew Willmott (ORCID: https://orcid.org/0000-0002-1971-4930)
- William Finnigan (ORCID: https://orcid.org/0000-0002-1061-7800)
- Francesco Falcioni
- William R. Birmingham (ORCID: https://orcid.org/0000-0002-8880-5502)
- Nicholas J. Turner (ORCID: https://orcid.org/0000-0002-8708-0781)
- Martin A. Hayes (ORCID: https://orcid.org/0000-0002-2640-8464)
- Sasha R. Derrington
Institutions
- AstraZeneca (United Kingdom) (GB)
- University of Manchester (GB)
- AstraZeneca (Sweden) (SE)
Publication Details
- Journal
- Nature Synthesis
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1038/s44160-024-00671-w
- Citations
- 13
- Primary Topic
- Biochemical and Molecular Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- AstraZeneca
- Medical Research Council
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council